HOME >> MEDICINE >> NEWS
Penn researchers demonstrate ability of new therapy to treat severely elevated cholesterol levels

(PHILADELPHIA) -- Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. The findings are in the January 11 issue of the New England Journal of Medicine (NEJM). In this study, patients with homozygous familial hypercholesterolemia (FH), a high-risk condition refractory to conventional therapy, had a remarkable 51% reduction in low-density lipoprotein (LDL) or "bad cholesterol" levels.

"Our study shows that targeted inhibition of the microsomal triglyceride transfer protein (MTP) is highly effective in reducing cholesterol levels in these very high risk patients," stated Daniel J. Rader, MD, Director of Preventive Cardiology and the Clinical and Translational Research Center at Penn, and principal investigator of this study. "Furthermore, there are many other patients who have cholesterol levels that are difficult to treat or who are not tolerant to treatment with statins. New therapies are required for these patients as well, and it is possible that after further research MTP inhibition could eventually be used for such patients."

Genetic defects in MTP lead to profoundly low levels of LDL. Using this information, Bristol-Myers Squibb began to search for inhibitors of this protein and discovered the study drug, originally known as BMS-201038. Bristol-Myers Squibb then donated it to Penn for use in clinical trials in patients with severe cholesterol problems. Rader and his team at Penn designed and carried out the current study in homozygous FH patients with support from the Doris Duke Charitable Foundation. Due to the success in this study, Penn has licensed the drug to Aegerion Pharmaceuticals Inc for further development as AEGR-733.

Patients who suffer from homozygous FH typically respond poorly to standard drug therapy and have a very high risk of premature cardiovascular disease. Homozygous FH is caused by los
'"/>

Contact: Susanne Hartman
susanne.hartman@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine
10-Jan-2007


Page: 1 2 3

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
3. Penn researchers discover novel pathway for increasing good cholesterol
4. Theory of facial aging gets a facelift from UT Southwestern researchers
5. UIC researchers to develop new drugs to fight bioterrorism
6. UQ researchers discover some of the oldest forms of life
7. U of M researchers discover new method to combat HIV
8. U of M researchers assess effectiveness of computerized physician order entry system
9. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
10. Physician-researchers often less successful in obtaining NIH funding
11. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2019)... (PRWEB) , ... May 23, 2019 , ... Mirror Mirror ... 100. This exciting landmark represents years of dedication to patient satisfaction and top-notch medical ... to provide a welcoming location where patients can come for exceptional skincare and innovative, ...
(Date:5/23/2019)... ... May 23, 2019 , ... Dr. Earl ... Beauty network. , The Haute Beauty Network, well known for their exclusivity, and ... and our newest addition to the Haute Living partnership. , Haute Beauty offers ...
(Date:5/23/2019)... ... 23, 2019 , ... Thermal Product Solutions, a global manufacturer ... to the Medical Industry. , These Gruenberg walk-in ovens have maximum temperature ratings ... 72” H. The Gruenberg truck-in ovens were constructed from a structural steel frame ...
(Date:5/23/2019)... ... 23, 2019 , ... Hoban Law Group is proud to be partnering with ... is essential to help educate the public about the most sweeping cannabis reform policy ... do so than Times Square,” said Hoban Law Group Founder & President Bob Hoban. ...
(Date:5/23/2019)... FRANKLIN, Tenn. (PRWEB) , ... May 23, 2019 ... ... treatment and behavioral health services, announces the opening of its seventeenth treatment center, ... residential treatment facility is Summit’s first in the Sunflower State. The facility is ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... ... May 23, 2019 , ... Educators at public K-12 ... Grant from California Casualty at http://www.calcasmusicartsgrant.com . The entry deadline is June 30, ... and hear over and over how their arts and performance programs could use more ...
(Date:5/22/2019)... ... , ... A leading global health expert urged new Western University of Health ... care successes and builds on them to make better lives for all the people ... at the University of Washington and Institute Director of the Institute for Health Metrics, ...
(Date:5/22/2019)... ... May 22, 2019 , ... Southern Illinois University Edwardsville’s Mark ... (SOP). Luer has served as interim dean since July 2018. The appointment is subject ... its outstanding record of accomplishment during Dr. Luer’s service as interim dean, and we ...
Breaking Medicine Technology:
Cached News: